Home › NDC Lookup › RxCUI directory › RxCUI 2058253

Clobazam 10 MG Oral Film — RxCUI 2058253

RxNorm drug concept · Semantic clinical drug
RxCUI 2058253 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2058253
Official nameClobazam 10 MG Oral Film
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)5,673 prescriptions · 18 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Clobazam: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Clobazam is an add-on medicine for seizures caused by Lennox-Gastaut syndrome in people 2 years and older. It is used along with other seizure medicines, not on its own.
  • Take it by mouth exactly as prescribed, usually split into two doses a day if your dose is above the lowest amount. You can take it with or without food. Tablets can be swallowed w...
  • No. Stopping suddenly can cause withdrawal reactions, including seizures, and can be life-threatening. Your prescriber will lower the dose slowly over time.
  • Sleepiness is the most common. You may also notice tiredness, fever, constipation, drooling, irritability, or poor balance. Call your doctor right away for a rash, breathing troubl...
📖 Read our full Clobazam guide →

🕸️ Concept Web — How Clobazam 10 MG Oral Film Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Clobazam 10 MG Oral Film RxCUI 2058253

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Clobazam 21241
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Sympazan 2102708
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Clobazam Oral Film 2269618
    • Clobazam Oral Film Product 2269617
    • Clobazam Oral Product 1163749
    • Clobazam Oral Film [Sympazan] 2269620
    • Sympazan Oral Film Product 2269621
    • Sympazan Oral Product 2102711
    • Oral Film 2269575
    • Oral Film Product 2269502
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Clobazam 10 MG SCDC · 331727
  • Clobazam Oral Film SCDF · 2269618
  • Clobazam Oral Film Product SCDG · 2269617
  • Clobazam Oral Product SCDG · 1163749

Brand-Name Concepts

  • Clobazam 10 MG Oral Film [Sympazan] SBD · 2102713
  • Clobazam 10 MG [Sympazan] SBDC · 2102709
  • Clobazam Oral Film [Sympazan] SBDF · 2269620
  • Sympazan Oral Film Product SBDG · 2269621
  • Sympazan Oral Product SBDG · 2102711
  • Sympazan BN · 2102708

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 2058253 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
10094-0205-60 60 POUCH in 1 PACKAGE (10094-205-60) / 1 FILM in 1 POUCH (1... SYMPAZAN Aquestive Therapeutics 2018-11-01
10094-0210-60 60 POUCH in 1 PACKAGE (10094-210-60) / 1 FILM in 1 POUCH (1... SYMPAZAN Aquestive Therapeutics 2018-11-01
10094-0220-60 60 POUCH in 1 PACKAGE (10094-220-60) / 1 FILM in 1 POUCH (1... SYMPAZAN Aquestive Therapeutics 2018-11-01
Observed labelers: Aquestive Therapeutics (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.